Indian court sets aside Roche’s patent (full version)
The Madras High Court last week set aside a patent granted to Swiss pharmaceutical company F Hoffman La Roche for its blockbuster anti-infection medicine valganciclovir because a pre-grant opposition by two NGOs was not heard.
The decision is another blow to Roche after the company failed to get a preliminary injunction in March against Indian generic drug maker Cipla, which is making its own version of Tarceva, Roches lung cancer medication. That case is currently...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.